Abbott Header Logo
Logo Image

ALINITY m HBV ASSAY

ALINITY m HBV ASSAY
ALINITY m HBV ASSAY
ALINITY m HBV ASSAY
ALINITY m HBV ASSAY ALINITY m HBV ASSAY

Accurate quantitation is critical to guide therapy and monitor Hepatitis B (which is important in limiting the spread of infection). The Alinity m HBV assay is an in vitro polymerase chain reaction (PCR) assay to quantitate Hepatitis B Virus (HBV) DNA in human plasma or serum.

  • State of the art assay design shaped by the information obtained from the Abbott Global Surveillance Program lead to a dual probe assay with highly conserved target region of the virus.
  • Sensitive quantitation across all genotypes for accurate therapy and viral load monitoring.

The Alinity m HBV assay is an in vitro polymerase chain reaction (PCR) assay for use with the automated Alinity m System to quantitate Hepatitis B Virus (HBV) DNA in human plasma or serum. The Alinity m HBV assay is intended for use as an aid in the management of patients with chronic HBV infection undergoing anti-viral therapy. The assay can be used to measure HBV DNA levels at baseline and during treatment to aid in assessing and monitoring response to treatment. The results from the Alinity m HBV assay must be interpreted within the context of all relevant clinical and laboratory findings. This assay is not intended to be used in screening blood, blood products, tissue or organ donors for HBV, or as a diagnostic test to confirm the presence of HBV infection.

 

 

 

ALINITY m HBV ASSAY PERFORMANCE  
 Limit of Detection (LoD)

 

Plasma: Probit analysis is 6.72 IU/mL [95% CI 5.28 to 9.27 IU/mL]

Serum: Probit analysis is 9.62 IU/mL [95% CI 7.14 to 14.43 IU/mL

LoD is 10 IU/mL in plasma and serum 

 Linear Range7 IU/mL to 2,000,000,000 IU/mL   
 Precision<0.22 Total SD  
 Specificity100.0% (95% CI: 99.3 to 100.0%)  
 Target RegionSurface Antigen gene   
 Genotype DetectionA, B, C, D, E, F, G, H, and I 
 Specimen Type

 

Plasma: Acid Citrate Dextrose (ACD); K2EDTA; K3EDTA, Plasma Preperation Tubes (PPT)*

Serum: Serum; Rapid clot tube (z-clot, thrombin, and similar); Serum separator tubes (SST)*

*Gel tubes  

 Standardizaiton3rd World Health Organization (WHO) International Standard [NIBSC code: 10/264; genotype A]  
 Internal ControlYes 
 Sample Input Volume300 µL 
Logo Image

© 2023 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Other trademarks are the property of their respective owners.

This Internet site that you have requested is intended for the residents of a particular country or countries and may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which this site is directed, contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?